<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Article Tag Suite 1.1//EN"
  "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         xmlns:mml="http://www.w3.org/1998/Math/MathML"
         article-type="research-article"
         xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>American Journal of Pharmacy and Health Research</journal-title>
        <abbrev-journal-title abbrev-type="publisher">AJPHR</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">2321-3647</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">AJPHR409007</article-id>
      <title-group>
        <article-title>A Clinical Study to Evaluate the Effect of An Ayurvedic Formulation in the Management of Pittaja Mutrakrchra W.S.R To Urinary Tract Infection</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Rekha</surname>
            <given-names>Phull</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>B.L</surname>
            <given-names>Mehra</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gaurav</surname>
            <given-names>Phull</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub" iso-8601-date="2016-09-01">
        <month>09</month>
        <day>01</day>
        <year>2016</year>
      </pub-date>
      <volume>4</volume>
      <issue>9</issue>
      <abstract>
        <p>Mutrakrchra is one of the commonest ailments which causes significant morbidity in females in developing countries.. Approximately 40-50% of adult females were reported to have UTI’s/Mutrakrchra. Almost every classical texts mentioned this disease in one or other way. Therefore, a clinical study was carried out as to explore Mutrakrchra from literary as well as management point of view, keeping in mind the scientific knowledge. Inspite of voluminous work done on Mutrakrchra and its management in Ayurveda, it still remains a common serious problem related to fatal complications. Therefore, in the present research work ,an indigenous and cost effective drug “Eladi  churna with Shatavryadi kwatha” was evaluated for its efficacy on scientific grounds to check or reduce the incidence of Pittaja Mutrakrchra. To evaluate the effect of “Eladi  churna with Shatavryadi kwatha” in the management of Pittaja Mutrakrchra. It is a double blind randomized study which was carried out by registering 34 patients of Pittaja Mutrakrchra. Eladi churna was given in a dose of 5gm TID with Shatavaryadi Kwatha  in a dose of  50ml BID for 21 days. It was seen that though the trial was of 21 days but patients were relieved in 7-15 days interval symptomatically and the repeat urine tests were also sterile after 15 days. Therefore, it can be concluded that both these drugs are quite effective in Pittaja Mutrakrchra patients. However, the drug can be made more palatable by converting churna form into vati. Keywords-Pittaja Mutrakrchra , Eladi Churan, Shatavryadi Kwatha, UTI.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <kwd>Pittaja Mutrakrchra</kwd>
        <kwd>Eladi Churan</kwd>
        <kwd>Shatavryadi Kwatha</kwd>
        <kwd>UTI.</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <!-- Full article body not available in metadata-only JATS export. See PDF/HTML galley. -->
  </body>
  <back/>
</article>
